Vaxcyte launches USD 500 million convertible senior notes offering due 2032

Bitget2026/10/05 20:28

Vaxcyte launched an underwritten public offering of USD 500 million of convertible senior notes due 2032. Notes set to mature on Oct. 15, 2032; interest rate and initial conversion rate to be fixed at pricing. Underwriters have a 30-day option to buy up to an additional USD 75 million of notes to cover over-allotments. Proceeds earmarked for VAX-31 clinical development, manufacturing scale-up, launch preparations, other R&D, working capital. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vaxcyte Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610051628PRIMZONEFULLFEED9839958) on October 05, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

The value of cryptocurrency assets held by the U.S. government has shrunk by $16 billion from last year’s peak.

AiCoin•2026/10/11 03:23

Copper prices approach historic highs! UBS remains bullish: "Still most optimistic"

华尔街见闻•2026/10/11 01:57

A COVID Vaccine Stock on the S&P 500 Is Up 600% This Year

BeInCrypto•2026/10/10 22:48

The number of stablecoin holders on the Solana chain has surpassed 14 million.

AiCoin•2026/10/10 21:35